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Abstract. Bacterial infection is the most common contamination on wound. Honey is one 
alternative plant by-product that can be used as treatment to the bacterial infection. This study 
aims to evaluate the antibacterial properties of Malaysian honey represented by Kelulut, Tualang 
and Acacia against fourteen clinically isolated bacteria strains from wound. Agar well diffusion 
assay was utilised to measure the diameter of inhibition zone. Determination of minimum 
inhibitory concentration and minimum bactericidal concentration were performed to evaluate the 
bacteriostatic and bactericidal effects of the honey. The antibacterial properties of Malaysian 
honey were compared with manuka honey (UMF 18+). Kelulut, Tualang and Acacia have the 
diameter of inhibition zones that ranged from 10.7 to 24.5 mm, 9.2 to 17.7 mm and no inhibition 
to 15.3 mm, respectively. Kelulut, Tualang and Acacia showed bacteriostatic effect against the 
bacteria at concentration of 50% (w/v) and below. Kelulut was the only honey that owned 
bactericidal effect against the fourteen bacteria while the effect was absence in Tualang and 
Acacia on E. coli, K. pneumonia, E. clocae and P. mirabilis. The antibacterial properties of 
Kelulut was comparable to manuka honey since both honey demonstrated bacteriostatic and 
bactericidal effects against the fourteen clinically isolated bacteria. 
1.  Introduction 
Bacterial infection is the most common contamination on wound [1,2] that delays the rate and reduce 
the quality of healing process by causing failure of grafts and flaps formation as a repair mechanism 
[3,4]. Due to its antibacterial properties, honey is one of the alternatives that can be used to prevent 
bacterial infection and improve the process of wound to heal. Based on its low pH, low water activity, 
and presence of antibacterial compounds i.e., peroxide and non-peroxide substances, honey provides a 
protective barrier which simultaneously treats and prevents microbial from infecting wound [5]. 
Honey has been proposed as antibacterial agent to treat bacterial infection. The advantages of using 
honey was due to its naturally available, non-toxic and most important, effective against resistant strains 
and does not reported to develop resistant strain [6,7]. Manuka was the honey that mostly used in clinical 
application in form of wound dressing and topical preparations such as hydrogel [8,9]. In recent years, 
there are numbers of preliminary studies conducted to evaluate the antibacterial properties of Malaysian 
honey against bacteria that associate with wound [10,11]. However, most studies have concentrated on 
the findings of Tualang despite other local honey such as Kelulut and Acacia. 
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Kelulut or stingless bee honey is produced by stingless bee from the genus trigona that was harvested 
from either meliponiculture or wild. The characteristics of this multiflora honey is depending mainly on 
the sources (nectar and pollen) collected by stingless bees and in Malaysia, the colour are ranged from 
light to dark amber [10,12] with identical sweet-sour taste. Tualang is a multiflora honey produced by 
the Apis dorsata which also known as Asian rock bees or the giant honey bee that collect pollen and 
nectar from various wild plants in Malaysia’s rainforest jungle and stored at the hive which built at the 
branches of the tualang tree or scientifically known as Koompassia excels [13]. Tualang can be found 
in dark to light amber colour and it taste can be varied between bitter-sweet and sweet-sour. Usually 
tualang that harvested in Malaysia is dark amber in colour with slightly bitter-sweet taste [10]. Acacia 
is a monoflora honey derived from Acacia mangium produced either by A. Mellifera or A. cerana [14,15] 
that usually harvested from apiculture with modern moveable comb hives that built in farm using wood. 
As the source of acacia was from Acacia mangium flower nectar [16] or honeydew [14], the taste of the 
honey is sweet and flowery. The colour usually found between light and slightly dark amber. 
Instead of being limitedly used as medicinal tonic [17], in this study, the implementation of 
Malaysian honey as an agent to eliminate the bacterial infection was studied by evaluating the 
antibacterial properties of Malaysian Kelulut, Tualang and Acacia against the fourteen clinical bacteria 
strains isolated from wound site of three patients. The antibacterial properties of the honey were 
evaluated through measurement of the diameter of inhibition zone, determination of minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC). 
2.  Materials and methods 
 
2.1. Preparation of honey 
Three types of honey were used throughout this study known as Kelulut, Tualang and Acacia. For each 
type, three samples were obtained from the local suppliers with certificate of analysis accredited by 
several authorised institutions including Malaysian Agriculture Research and Development Institute 
(MARDI) and Food Quality and Safety Research and Development (UNIPEQ) for its authenticity and 
quality. The colour and pH of the honey was tabulated in Table 1. The commercially available medical-
grade honey, Manuka (Comvita® Wound care UMF 18+, New Zealand) was used as a basis of 
comparison to verify the reliability of these studies. 
A series of honey samples was prepared in different range of concentrations. For the determination 
of MIC and MBC, samples were prepared for each honey with dilution ranging from 5 to 90% (w/v) 
concentrations by using nutrient or soy broth as the diluents. In both evaluations, sugar-based honey 
(SB) were used as an artificial honey containing the major sugar compounds that commonly present in 
honey such as fructose, glucose, maltose and sucrose which mixed at proportion of 40%, 30%, 8% and 
2% (w/v) respectively in sterile water [18]. 
 
2.2. Preparation of bacteria 
Fourteen bacterial strains were kindly supplied by the Department of Pathology & Laboratory Medicine, 
International Islamic University Malaysia Medical Centre (IIUMMC) which were clinically isolated 
from tissues, pus or swabs of three different patients with infected foot ulcer and soft tissue. Among the 
fourteen clinical isolated strains, five were Gram-positive which were Staphylococcus aureus, 
Staphylococcus hominis, Staphylococcus haemolyticus, Streptococcus pyogenes, and Streptococcus 
agalactiae. The remaining nine bacteria strains were Gram-negative and known as Acinetobacter 
baumannii, Proteus mirabilis, Proteus vulgaris, Enterobacter aerogenes, Enterobacter clocae, 
Pseudomonas aeruginosa, Klebsiella pneumonia, Salmonella sp., and Escherichia coli. The isolation 
of bacteria was performed following a standard procedure of bacteria isolation and identification [19] 
with approval of the IIUM Research Ethics Committee (IREC) (Approval number: IREC 2019-062). 
The isolated bacteria were inoculated into a sterile tube containing nutrient or soy broth (which is 
known as overnight culture) and incubated in a shaker incubator (Infors AG CH-4103 Bottmingen) at 
the temperature of 37 ºC, rotational speed of 120 rpm for 24 hours. Nutrient-based media (nutrient agar 
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and broth) was used to inoculate the bacteria except for Streptococcus pyogenes and Streptococcus 
agalactiae that were inoculated in the soy-based media (soy agar and broth). The inoculum was 
standardised at a final concentration of 1 x 108 colony forming units (CFU/ml) which is equal to 0.5 
McFarland standard. The inoculum was prepared based on the optical density by diluting the overnight 
culture in fresh sterile broth to be in the absorbance range between 0.08 and 0.13 at 600 nm [20]. This 
culture served as the working bacteria for the subsequent assays during the determination of inhibition 
zone, MIC and MBC. 
Table 1. The colour and pH of the honey samples. 
Sample Colour pH 
Kelulut 1 Dark amber 2.37 ±0.13 
Kelulut 2 Dark amber 2.39 ±0.08 
Kelulut 3 Dark amber 2.35 ±0.05 
Tualang 1 Dark amber 3.88 ±0.04 
Tualang 2 Dark amber 3.94 ±0.04 
Tualang 3 Dark amber 3.92 ±0.05 
Acacia 1 Light amber 4.17 ±0.01 
Acacia 2 White 4.25 ±0.09 
Acacia 3 Light amber 4.24 ±0.09 
The symbol ± represents the standard deviation calculated between three biological replicates. 
 
2.3. Measurement of inhibition zone through agar well diffusion assay 
The measurement of inhibition zone was performed through the agar well diffusion assay which has 
been adapted from [21,22] with slight modifications. Agar was prepared according to the manufacturer’s 
instructions. All honey samples were represented by three samples from each type of honey used. The 
inhibition zones of the honey were measured against fourteen clinically isolated bacteria. The working 
bacteria was inoculated using the pour plate technique by spreading 100 µL of the adjusted 0.5 
McFarland culture on the agar surface. Each bacteria species was inoculated in a different plate. Upon 
inoculation, six mm diameter wells were cut on the agar surface to fill 80 µL of the test honey into the 
created well. Manuka was used as the positive control. Plates were incubated at 37ºC for 24 hours. The 
inhibition zone was determined by measuring the diameter of circular area that was formed on the 
surface of agar in millimetre (mm), including the diameter of well created. Each assay was carried out 
in triplicates. Based on the inhibition zone measured, the sensitivity of bacteria towards honey was 
categorised as not sensitive, sensitive, very sensitive and extremely sensitive as previously described 
[22]. The not-sensitive was denoted as the diameter of inhibition zone of lower than eight mm, sensitive 
for diameter from eight to fourteen mm, very-sensitive for diameter from fifteen to nineteen mm, and 
extremely-sensitive for diameter of twenty mm and above. 
 
2.4. Minimum inhibitory concentration (MIC) 
Determination of MIC and MBC were performed on one sample of Kelulut, Tualang and Acacia which 
the selection was based on the largest inhibition zone measured, representing higher antibacterial 
properties compared to the other samples. Based on the results obtained, Kelulut 1, Tualang 2 and Acacia 
1 were selected. The MIC of each bacteria was determined by conducting the previously described 
methods with slight modifications [21]. This assay was performed in sterile 96 well round flat-bottom 
polystyrene microtitre plates Nunclon™ (Thermo Fisher Scientific, US). The honey samples which 
prepared as described in the previous section were dispensed into the test and control wells. It was 
performed by taken out 190 µl of the diluted honey sample from each concentration and aseptically 
transferred to the prepared 96-well plate containing 10 µl bacteria culture that has been adjusted to 0.5 
McFarland standard. In this study, the antibacterial-free broth (without honey) served as viability 
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controls and bacteria-free broth (without honey and inoculum) served as sterility controls. The prepared 
microplate was then incubated in the shaker incubator (Infors AG CH-4103 Bottmingen) at 37 ºC, 120 
rpm for 24 hours. The absorbance of the samples was quantified by using a microplate reader (Infinite® 
M200PRO, Tecan Group Ltd., Switzerland) at a time before incubation (known as t = 0) and at an 
elapsed time after 24 hours of incubation (known as t = 24) at a wavelength of 590 nm. The percentage 
of growth inhibition (PGI) was calculated using Equation (1). MIC value refers to the lowest 
concentration of a test material which results from 95% and above growth inhibition of the test organism. 
 
 = 1 − 	
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 	    ( )	
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	  × 100% (1) 
 
2.5. Minimum bactericidal concentration (MBC) 
The MIC determination provides insights about the concentration at which the bacteria growth is 
inhibited, the concentration at which it becomes suicidal to the bacteria was evaluated through the MBC 
determination. Based on MIC determination, the wells which resulted on 95% and above of growth 
inhibition were selected and one loopful suspension was retrieved and sub-cultured on freshly prepared 
Trypticase Soy Agar (TSA) using streak plate method [15] before being incubated at 37 ºC for 24 hours. 
These samples were then subsequently examined for any bacterial growth through formation of colony. 
Each test was performed in three biological replicates. The honey was considered as bacteriostatic if 
growth occurred and bactericidal if inhibition of growth persisted [11,15]. The lowest concentration 
with no growth of test organisms was considered as the MBC. 
3.  Results and discussion 
 
3.1. Measurement of inhibition zone through agar well diffusion assay 
The diameter of the inhibition zones on fourteen bacteria were measured and the results are tabulated in 
Table 2. The definition on sensitivity of bacteria toward honey was categorised as not sensitive (<8mm), 
sensitive (8 to 14 mm), very sensitive (15 to 19 mm) and extremely sensitive (20 mm and above) [22]. 
Kelulut has the diameter of inhibition zones ranged from 10.7 ±1.15 to 24.5 ±0.50 mm, indicating the 
susceptibility of bacteria toward Kelulut were varied between sensitive and extremely sensitive. Tualang 
recorded range of inhibition zone from 9.2 ±0.76 to 17.7 ±0.58 mm which the bacteria responded 
between sensitive and very sensitive toward Tualang. Acacia demonstrated the lowest antibacterial 
properties as it was the only honey that resulted with no inhibition on several bacteria including P. 
aeruginosa, K. pneumonia, E. clocae and P. mirabilis. The inhibition zone for Acacia ranged from no 
inhibition to 15.3 ±2.52 mm which the susceptibility of bacteria toward Acacia varied between not 
sensitive and very sensitive. The not sensitive response were demonstrated by nine bacteria including S. 
aureus, S. hominis, P. aeruginosa, K. pneumonia, A. baumannii, E. clocae, P. mirabilis and P. vulgaris 
towards Acacia. 
In comparing between Malaysian honey, Kelulut showed the diameter of inhibition zones of more 
than 15 mm (very sensitive) on six bacteria - S. hominis, S. haemolyticus, Salmonella sp., E. aerogenes, 
P. mirabilis, and P. vulgaris while S. haemolyticus was the only bacteria that resulted more than 15 mm 
(very sensitive) toward Tualang and Acacia. Present study support the antibacterial properties possess 
by Acacia is likely caused by osmotic pressure due to presence of high sugar content as the diameter of 
inhibition zone measured for Acacia was similar to that of SB [23,24]. For Manuka, all bacteria were 
inhibited at diameter of inhibition zone of more than 15 mm (very sensitive and above), except on P. 
aeruginosa and P. mirabilis with inhibition zone of 9.0 ±0.00 and 10.8 ±0.29 mm, respectively. In 
comparing between Manuka and Malaysian honey, Kelulut was the only honey that demonstrated larger 
inhibition zone than Manuka. The effect was observed on P. aeruginosa, P. mirabilis and P. vulgaris 
with inhibition zone of 12.8 ±0.29 mm, 17.7 ±1.53 mm, and 20.7 ±1.15 mm, respectively and were 1.4, 
1.6, and 1.2-fold larger than Manuka, respectively. 
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3.2. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) 
Further evaluation on antibacterial properties were done to identify the bacteriostatic and bactericidal 
effects owned by the honey. It was performed through determination of MIC and MBC, and the results 
are tabulated in Table 3. Kelulut demonstrated the MIC of below 20% (w/v) against the fourteen bacteria 
and the results were consistent with the previous study [15]. As compared to Tualang and Acacia, higher 
MIC were recorded which were below 40% and below 50% (w/v), respectively. For Manuka and SB, 
the MIC of not more than 15% and 60% (w/v) were recorded respectively. When compared between 
Manuka and Malaysian honey, Kelulut was the only honey that has lower MIC than Manuka which 
demonstrated on E. coli, P. aeruginosa, and P. vulgaris with the MIC of <5%, <5% and 7.5% (w/v), 
respectively as compared to manuka with 10%, 15%, and 10% (w/v), respectively. Also, similar MIC 
values were recorded on Kelulut and Manuka for S. haemolyticus, A. baumannii, S. agalactiae and E. 
aerogenes at <5%, <5%, 10% and 12.5% (w/v), respectively. 
The results showed a different pattern for MBC evaluation. Manuka honey was observed to be 
generally stronger bactericidal agent as compared to Kelulut, Tualang and Acacia with the MBC ranged 
between 5% and 25% (w/v) to the tested bacteria, except on P. aeruginosa. Kelulut and Tualang has the 
MBC range from 12.5% to 40% (w/v) and from 30% to >90% (w/v), respectively. Acacia was the least 
strong bactericidal agent as the MBC were recorded to be generally >90% except for P. aeruginosa and 
P. vulgaris which were 50%, and 40% (w/v), respectively. MBC of Kelulut was recorded to be similar 
to Manuka which was at 20% (w/v) for S. pyogenes and S. agalactiae and 25% (w/v) for E. aerogenes, 
respectively. Interestingly, Kelulut has the lowest MBC of <5% (w/v) on P. aeruginosa and 
demonstrated as the most potent antibacterial agent to P. aeruginosa due to the lowest MIC and MBC 
recorded. The results were in a good agreement with the previous work that recorded the MIC and MBC 
of stingless bee honey on P. aeruginosa at 5% and 10% (w/w), respectively [25]. 
Among the tested Malaysian honey, Kelulut was the only honey that showed both bacteriostatic and 
bactericidal effects against the fourteen bacteria strains indicating potent antibacterial properties. The 
antibacterial action of Kelulut was reported to be due to presence of hydrogen peroxide (H2O2) [15], 
phenolics and flavonoids compounds [25–27] and acidic environment [26,28]. Among the factors, acidic 
environment was most prominent cause that influence the antibacterial properties of Kelulut [26] with 
the range of pH for between 2.4 to 3.4 [29]. In this study, the strong acidic environment was also 
recorded in Kelulut in which the average pH was 2.37 and was lowered by 1.78 and 1.65-fold as 
compared to Tualang and Acacia. This may explained the effectiveness of Kelulut to eliminate P. 
aeruginosa since its optimum pH for growth was 6.6 to 7.0 [30]. In addition, the physical appearance of 
dark amber in Kelulut (Table 1) indicate that the honey contains high phenolics and flavonoids 
compounds [25,27,31,32]. These compounds possess antimicrobial effect on its own and the effect may 
increase if combine with strong acidic environment [33]. This was expected to be the additional factors 
that enhanced the antibacterial properties of Kelulut as compared to Tualang and Acacia. 
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Table 3. MIC and MBC of tested honey against fourteen clinical isolated bacteria. 
Bacteria 
Kelulut Tualang Acacia Manuka SB 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
Gram-positive 
S. aureus 10% 30% 40% 50% 30% >90%b <5% a 5% 50% >90%b 
S. hominis 6.25% 25% 15% 30% 50% >90%b <5% a 7.5% 60% >90%b 
S. haemolyticus <5% a 25% 12.5% 50% 40% >90%b <5% a 7.5% 40% >90%b 
S. pyogenes 20% 20% 30% 60% 30% >90%b 10% 20% 40% >90%b 
S. agalactiae 10% 20% 30% 60% 40% >90%b 10% 20% 40% >90%b 
Gram-negative 
E. coli 7.5% 40% 25% >90%b 40% >90%b 10% 12.5% 40% >90%b 
P. aeruginosa <5%a 12.5% 20% 40% 30% 50% 15% 20% 40% >90%b 
K. pneumonia 10% 30% 40% >90%b 30% >90%b 6.25% 10% 40% >90%b 
Salmonella sp. 7.5% 25% 20% 60% 40% >90%b 6.25% 10% 40% >90%b 
A. baumannii, <5% a 12.5% 15% 60% 30% >90%b <5% a 7.50% 30% >90%b 
E. clocae 7.5% 20% 25% >90%b 50% >90%b 6.25% 10% 50% >90%b 
E. aerogenes 12.5% 25% 30% 60% 40% >90%b 12.5% 25% 50% >90%b 
P. mirabilis 7.5% 25% 25% >90%b 40% >90%b 12.5% 15% 50% >90%b 
P. vulgaris <5% a 20% 15% 30% 25% 40% 10% 12.5% 50% >90%b 
a The lowest concentration tested.  
b The highest concentration tested.  
One sample t-test shown significant differences for the data collected (P-value < 0.05). 
 
Based on our observation from Quadrupole Time-of-Flight Mass Liquid Chromatography-mass 
Spectrometer (LCMS-QTOF), Kelulut had compounds such as reptoside, saikosaponin and 8-O 
acethylharpagide which were absence in Tualang and Acacia (data not shown) and these compounds 
have been associated with antibacterial properties and defend mechanism against bacterial infection 
[34–36]. The data may additionally explained the wide coverage of bactericidal effect in Kelulut against 
wound infectious bacteria. 
In this study, S. pyogenes was inhibited at the highest concentration of Kelulut. This can be due to 
its ability to develop resistant mechanism such as biofilm formation to become less susceptible. Similar 
pattern was demonstrated by other types of honey in which higher concentration was require to inhibit 
S. pyogenes. However, once inhibited, S. pyogenes was simultaneously destroyed by Kelulut. The 
finding was in line with previous study that recorded simultaneous effects of both bacteriostatic and 
bactericidal at the same concentration of Kelulut on other bacteria species – S. aureus, E. coli, P. 
aeruginosa and B. cereus [15]. In contrast, E. coli was inhibited at low concentration of 7.5 (w/v) and 
require higher concentration to be killed by Kelulut which was at 40% (w/v). This could be due to the 
ability of cell wall peptidoglycan of E. coli to recover from disruption and resist penetration of 
compounds at low concentration of honey to promote cell lysis. Previous study has also reported a 
variation gap of bacteriostatic and bactericidal effects of Kelulut on E. coli with the MIC at 8% and 
MBC at 32%, respectively [28]. Similar condition were also notified on Tualang and Acacia which 
inhibit E. coli at low concentration (MIC of <40%), but refuse to abolish the bacteria even at highest 
concentration (90%).  
In many types of acute and chronic wounds, S. aureus and P. aeruginosa are usually isolated from 
the infected wounds [37,38]. These bacteria often causes biofilm chronic infections which may suppress 
immune and antimicrobial activities, and promotes on the development of antibiotic resistance strain 
[38]. Similar to S. aureus and P. aeruginosa, other wound associate bacteria such as S. pyogenes, P. 
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mirabilis, and E. clocae can also develop biofilm as a resistance mechanism [39]. In this study, these 
bacteria that isolated from the infected wound site have been tested and found to be susceptible to the 
tested honey, especially on Kelulut. The antibacterial properties of Kelulut was demonstrated to be 
higher than Manuka on certain well-known biofilm-formation organisms – P. aeruginosa and P. 
mirabilis. Further evaluation to confirm on ability and factors that contribute to eradicate biofilm 
formation by Kelulut is necessary as the finding is beneficial in order to suppress the resistant 
mechanism owned by those infectious bacteria. 
4.  Conclusion 
Malaysian Kelulut, Tualang and Acacia honey do possess antibacterial properties against the clinically 
isolated bacteria from wound which confirmed through manifestation of inhibition zone, bacteriostatic 
and bactericidal effects. Among the honey, Kelulut demonstrated the highest antibacterial properties 
since both bacteriostatic and bactericidal effects was owned by Kelulut against the fourteen clinical 
isolated bacteria. The similar effects was absence on Tualang and Acacia. Further evaluation on 
compounds that contribute to the antibacterial properties of Malaysian Kelulut, Tualang, and Acacia are 
necessary to potentially utilise the honey as an alternative to prevent bacterial infection. 
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